Estimating hospital admissions due to respiratory syncytial virus in children
- PMID: 36495914
- DOI: 10.1016/S1473-3099(22)00809-X
Estimating hospital admissions due to respiratory syncytial virus in children
Conflict of interest statement
PH holds, or has held, grants from UKRI–MRC, UKRI–ESRC, NIHR, and Wellcome Trust, and has acted as an unpaid consultant or advisor to MSD, AstraZeneca, and Pfizer. RMR is currently employed by GSK Vaccines and previously received consultancy fees from Sanofi Pasteur.
Comment in
-
Estimating hospital admissions due to respiratory syncytial virus in children - Authors' reply.Lancet Infect Dis. 2023 Jan;23(1):33-34. doi: 10.1016/S1473-3099(22)00815-5. Epub 2022 Dec 7. Lancet Infect Dis. 2023. PMID: 36495915 No abstract available.
Comment on
-
Epidemiology of respiratory syncytial virus in children younger than 5 years in England during the COVID-19 pandemic, measured by laboratory, clinical, and syndromic surveillance: a retrospective observational study.Lancet Infect Dis. 2023 Jan;23(1):56-66. doi: 10.1016/S1473-3099(22)00525-4. Epub 2022 Sep 2. Lancet Infect Dis. 2023. PMID: 36063828 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical